Glucose B. Braun Vet Care 50 mg/ml Solution for Infusion for Cattle, Horses, Sheep, Goats, Pigs, Dogs and Cats

Excipient:
Qualitative composition of excipients and other constituentWater for injections
Caloric value 837 kJ/l = 200 kcal/l
Theoretical osmolarity 278 mOsm/l
pH value 3.5 - 5.5
Clear, colourless or almost colourless aqueous solution, free from visible
particles.
3. CLINICAL INFORMATION
3.1 Targets species
Cattle, horses, sheep, goats, pigs, dogs and cats
3.2 Indications for use for each targets species
- Treatment of dehydration (in the absence of shock)
- Parenteral rehydration
- Correction of hypernatremia
- Correction of hyperkalaemia
- Transient supportive treatment of hypoglycaemia
3.3 Contraindications
Do not use in animals with hyperglycaemia.
Do not use for the correction of hypotonic dehydration.
Do not use in animals with pre-existing peripheral oedema caused by a
reduction in intravascular oncotic pressure.
This veterinary medicinal product is not suitable as a sole source of calorie
requirements or as a substitute for oral or parenteral nutrition.
AN: 04311/2024 & 04312/2024
3.4 Special warnings
None.
3.5 Special precautions for use
Special precautions for safe use in the target species:
This veterinary medicinal product does not contain electrolytes. Care should be taken
to closely monitor electrolyte and phosphate balance in patients undergoing infusion
of this product, and to adjust treatment accordingly.
This veterinary medicinal product should be used with particular caution in animals
with the following conditions:
•
•
•
•
Severe or long standing hypernatraemia should be corrected gradually.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
Not applicable.
Special precautions for the protection of the environment:
Not applicable.
3.6 Adverse events
Cattle, horses, sheep, goats, pigs, dogs and cats
Very rare
(<1 animal / 10,000 animals treated, including
isolated reports):
ThrombosisUndetermined frequency (cannot be estimated from
the available data)
Glycosuria
, osmotic
diuresis
1
If the product is administered at a rate in excess of 10 ml/kg bodyweight/hour.
Please refer to sections 3.9 “Administration routes and dosage”.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See package leaflet for
respective contact details.
3.7 Use during pregnancy, lactation or lay
Pregnancy and lactation:
The safety of the veterinary medicinal product has not been established during
pregnancy and lactation. Use only according to the benefit-risk assessment by
the responsible veterinarian.
AN: 04311/2024 & 04312/2024
3.8 Interaction with other medicinal products and other forms of interaction
Incompatibilities with certain antibiotics (e.g. beta-lactam antibiotics,
tetracyclines, sulfadiazine sodium) and heparin are recognised.
3.9 Administration routes and dosage
Intravenous use. Administer slowly via intravenous infusion.
For single use only.
This veterinary medicinal product should not be administered at a rate in
excess of 10 ml/kg bodyweight/hour, otherwise glycosuria and osmotic diuresis
may result.
Infusion rates should be calculated according to the presenting condition,
bodyweight and degree of dehydration of the animal being treated.
The total fluid volume to be administered should consider existing deficits,
maintenance requirements and ongoing losses.
IV fluids should be warmed up to body temperature prior to administration.
Maintain aseptic precautions throughout administration.
Do not use unless the solution is clear, free from visible particles, and the
container is undamaged.
3.10 Symptoms of overdose (and where applicable, emergency procedures and
antidotes)
Overperfusion can lead to overhydration, hypertension and extravascular fluid
accumulation. Symptoms may include respiratory distress. In the case of
overperfusion, reduce or cease fluid infusion and administer oxygen, diuretics
and adjunctive treatment as necessary. Monitor respiration and heart rate, fluid
output, electrolyte balance and blood glucose during administration.
The administration of excess glucose can lead to hyperglycaemia, glycosuria
and polyuria.
3.11 Special restrictions for use and special conditions for use, including
restrictions on the use of antimicrobial and antiparasitic veterinary
medicinal products in order to limit the risk of development of resistance
For administration only by a veterinarian.
3.12 Withdrawal periods
Cattle, horses, sheep, goats, pigs:
Meat and offal: Zero days
Cattle, horses, sheep, goats:
Milk: Zero hours
4.